| Title
of the article |
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. |
| Authors |
Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S, Minar E, Muller M, Wolzt M, Schillinger M |
| Journal
|
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2536-40 |
| Subject
Consultant |
F. Mallamaci |
| Score
(1 to 3 stars) |
*** |
| Comments |
High ADMA plasma concentrations independently predict major adverse cardiovascular events (MACE) in patients with advanced PAD. This indicates that ADMA may be a new cardiovascular risk marker in these patients. |
